You have accessed back-upped version of our site. Please reffer to new home page for a more up-to-date information.
Virtual screening services
Quantum is a leading company providing drug screening services in-silico and, thus, delivering to it clients strong inhibitors against variety of target-proteins
We apply our proprietary developed computational technology QUANTUM, which shows outstanding accuracy in forecasting binding affinities. The hit rate of the QUANTUM performance is about 50%, it means that a half of found in silico strong inhibitors would be confirmed in in-vitro testing!!!
Click here to download a brochure about QUANTUM hit Identification technology.
|
|
Title: Crystal structure of a Monooxygenase from the gene ActVA-Orf6 of Streptomyces coelicolor in complex with the ligand Acetyl Dithranol |
|
 |
Functional Class: Oxidoreductase Primary citation: Sciara, G.,Kendrew, S.G.,Miele, A.E.,Marsh, N.G.,Federici, L.,Malatesta, F.,Schimperna, G.,Savino, C.,Vallone, B. The structure of ActVA-Orf6, a novel type of monooxygenase involved in actinorhodin biosynthesis Embo J. v22 pp.205-215, 2003 |
Abstract Title: The structure of ActVA-Orf6, a novel type of monooxygenase involved in actinorhodin biosynthesis.
Keywords: Proteins, Antibiotic, Oxygenases, Cytoplasm, Support, Research, Mixed, D1n5sb_, Actinorhodin, Molecular, Alignment, Function, 1n5sb0, Streptomyces, Acid, (1n5s:a,, Models, Sandwich, (a+b), Anthraquinones, Beta, Actva-, Alpha, Ethoxy)-ethanol, Data, Structure, Alpha+beta, Alpha-beta, Orf6, Folding, 1n5sa0, Oxygen, 2-yl)-acetic, 2-layer, Activity, Dimeric, (1,8-dihydroxy-9-oxo-9,10-dihydro-anthracen-, Sites, Biosynthesis, Beta, Ferredoxin-like, D1n5sa_, Oxidoreductase, Non-u.s., Actva-orf6, 2-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-, Acid, Tertiary, Sequence, Coelicolor, Monooxygenase, Binding, Barrel, Agents, Anti-bacterial, Plaits, Oxidoreductase, Protein, Crystallography, Gov't, Bacteria, X-ray, Amino, Focused compound library, Targeted chemical collection, Pre-selected, Prescreened, Measurement, Estimation, Prediction, Hts, Uhts, High throughput screening, Ultra high-throughput screening, Development, Profiling, Hit, Lead, Hits, Leads, Drug candidate, Chemicals, Entity, Therapeutic agents, Small molecules, In vitro, Novel active compounds, Focused compound library, Targeted hit library, Entities collection, In-vitro, Vendors, Providers, Distributors, Cro, Medicinal chemists, Diverse range, Structurally diverse building blocks, Hit rich collection, Synthesized, Develop new focused arrays, Privileged scaffolds profile, Profiling, Pre-screened, Methods and principles in medicinal chemistry, Synthetic organic, Computational chemistry, Subset of, Broad variety of organic compounds, Diversity analysis, Synthetic tractability and drug like properties, Computer-aided, Optimization,
